To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Idiopathic Pulmonary Fibr… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease

Journal article
Authors W. A. Wuyts
M. Wijsenbeek
B. Bondue
D. Bouros
P. Bresser
C. R. Cordeiro
O. Hilberg
Jesper Magnusson
E. D. Manali
A. Morais
S. Papiris
S. Shaker
M. Veltkamp
E. Bendstrup
Published in Respiration
Volume 99
Issue 1
Pages 73-82
ISSN 0025-7931
Publication year 2020
Published at Institute of Medicine, Department of Internal Medicine and Clinical Nutrition
Pages 73-82
Language en
Links dx.doi.org/10.1159/000504763
Keywords Nintedanib, Pirfenidone, Interstitial lung disease, Therapeutics, Treatment, Mortality, forced vital capacity, quality-of-life, clinical-practice, acute, exacerbation, lung-transplant, antacid therapy, home spirometry, palliative care, position paper, survival, Respiratory System
Subject categories Clinical Medicine

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease that is, by definition

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?